
CMSC | -0.28% | 22.547 | $ | |
SCU | 0% | 12.72 | $ | |
RYCEF | -1.36% | 13.2 | $ | |
BCC | -1.74% | 84.67 | $ | |
RBGPF | -4.75% | 74.03 | $ | |
JRI | 0.68% | 13.15 | $ | |
SCS | -1.45% | 10.36 | $ | |
RIO | -4.96% | 59.325 | $ | |
NGG | -0.35% | 70.275 | $ | |
CMSD | -0.46% | 23.015 | $ | |
BCE | -0.7% | 23.495 | $ | |
VOD | -0.5% | 11.055 | $ | |
GSK | 2.94% | 38.81 | $ | |
RELX | -0.62% | 51.6 | $ | |
BTI | 0.85% | 53.22 | $ | |
AZN | 3.21% | 76.435 | $ | |
BP | -2.92% | 32.025 | $ |
Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, today announced that it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT.
Interested parties may participate in the call by dialing:
(877) 407-6176 (US Toll-Free)
+1 (201) 689-8451 (International)
Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=4jnXGdPH
Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
ABOUT VIEMED HEALTHCARE, INC.
Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at www.viemed.com.
For further information, please contact:
Investor Relations
[email protected]
Tripp Sullivan
SCR Partners, LLC
615-942-7077
Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
337-504-3802
SOURCE: Viemed Healthcare, Inc.
View the original press release on ACCESS Newswire
F.Leblanc--SMC